These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32703926)

  • 1. Prognostic Value of Enolase Gene Family in Colon Cancer.
    Pan X; Wu H; Chen G; Li W
    Med Sci Monit; 2020 Jul; 26():e922980. PubMed ID: 32703926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ENO3 promotes colorectal cancer progression by enhancing cell glycolysis.
    Chen J; Zhang Z; Ni J; Sun J; Ju F; Wang Z; Wang L; Xue M
    Med Oncol; 2022 Apr; 39(5):80. PubMed ID: 35477821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ENO2 Promotes Colorectal Cancer Metastasis by Interacting with the LncRNA CYTOR and Activating YAP1-Induced EMT.
    Lv C; Yu H; Wang K; Chen C; Tang J; Han F; Mai M; Ye K; Lai M; Zhang H
    Cells; 2022 Aug; 11(15):. PubMed ID: 35954207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A five-immune-related genes-based prognostic signature for colorectal cancer.
    Zhu L; Wang H; Wang Z
    Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Significance of the Hsp70 Gene Family in Colorectal Cancer.
    Jiang W; Pan X; Yan H; Wang G
    Med Sci Monit; 2021 Feb; 27():e928352. PubMed ID: 33600380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Integrated miRNA-lncRNA Signature Predicts the Survival of Stage II Colon Cancer.
    Wang XJ; Zeng B; Lin S; Chen M; Chi P
    Ann Clin Lab Sci; 2019 Nov; 49(6):730-739. PubMed ID: 31882423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over-Expression of Alpha-Enolase as a Prognostic Biomarker in Patients with Pancreatic Cancer.
    Sun L; Guo C; Cao J; Burnett J; Yang Z; Ran Y; Sun D
    Int J Med Sci; 2017; 14(7):655-661. PubMed ID: 28824297
    [No Abstract]   [Full Text] [Related]  

  • 8. Integrative Gene Expression Profiling Analysis to Investigate Potential Prognostic Biomarkers for Colorectal Cancer.
    Liu X; Bing Z; Wu J; Zhang J; Zhou W; Ni M; Meng Z; Liu S; Tian J; Zhang X; Li Y; Jia S; Guo S
    Med Sci Monit; 2020 Jan; 26():e918906. PubMed ID: 31893510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a five-gene signature with prognostic value in colorectal cancer.
    Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z
    J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
    Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of differentially expressed genes regulated by methylation in colon cancer based on bioinformatics analysis.
    Liang Y; Zhang C; Dai DQ
    World J Gastroenterol; 2019 Jul; 25(26):3392-3407. PubMed ID: 31341364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival marker genes of colorectal cancer derived from consistent transcriptomic profiling.
    Martinez-Romero J; Bueno-Fortes S; Martín-Merino M; Ramirez de Molina A; De Las Rivas J
    BMC Genomics; 2018 Dec; 19(Suppl 8):857. PubMed ID: 30537927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification prognosis-associated immune genes in colon adenocarcinoma.
    Miao Y; Wang J; Ma X; Yang Y; Mi D
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Prognostic Significance of HOXC9 Expression in Patients with Colorectal Cancer.
    Hu M; Ou-Yang W; Jing D; Chen R
    Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated Analysis of the Role of Enolase 2 in Clear Cell Renal Cell Carcinoma.
    Pan J; Jin Y; Xu X; Wei W; Pan H
    Dis Markers; 2022; 2022():6539203. PubMed ID: 36419844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients.
    Fan Q; Liu B
    J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulated SPINK4 is associated with poor survival in colorectal cancer.
    Wang X; Yu Q; Ghareeb WM; Zhang Y; Lu X; Huang Y; Huang S; Sun Y; Lin J; Liu J; Chi P
    BMC Cancer; 2019 Dec; 19(1):1258. PubMed ID: 31888570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression and Selective Anticancer Efficacy of
    Park C; Lee Y; Je S; Chang S; Kim N; Jeong E; Yoon S
    Mol Cells; 2019 Nov; 42(11):804-809. PubMed ID: 31697874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a prognostic index and screening of potential biomarkers based on immunogenomic landscape analysis of colorectal cancer.
    Lin K; Huang J; Luo H; Luo C; Zhu X; Bu F; Xiao H; Xiao L; Zhu Z
    Aging (Albany NY); 2020 Mar; 12(7):5832-5857. PubMed ID: 32235004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring prognostic potential of long noncoding RNAs in colorectal cancer based on a competing endogenous RNA network.
    Yang ZD; Kang H
    World J Gastroenterol; 2020 Mar; 26(12):1298-1316. PubMed ID: 32256018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.